drugset / Trial / NCT07627360

PRO STRESS Trial: Proactive Low-Dose Norepinephrine to Reduce Intraoperative Fluid Administration in Patients at High-Risk for Postoperative Pulmonary Complications Undergoing Laparoscopic Abdominal Surgery

NCT07627360

Not yet recruiting 130 enrolled Suez Canal University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Intraoperative hypotension is commonly treated with fluid administration; however, excessive fluid therapy may contribute to postoperative pulmonary complications. This randomized double-blind controlled trial evaluates whether proactive administration of fixed low-dose norepinephrine reduces intraoperative crystalloid administration while maintaining hemodynamic stability in high-risk patients undergoing laparoscopic abdominal surgery. One hundred and thirty patients will be randomized to receive either norepinephrine infusion (0.03 µg/kg/min) or placebo from induction until skin closure within a protocolized hemodynamic strategy guided by mean arterial pressure and pulse pressure variation.

Timeline

Start
2026-07-15
Primary completion
2026-10
Completion
2026-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Norepinephrine Other / unclassified 0.03 ug/kg

Indications

No indication recorded.